RxDoctor Payments Data

Michael Hart

Family · Peoria, AZNPI 1548235773

Payments from drug & device makers

$2,800in general payments, 2019–2025

Across 141 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$437
  • Novo Nordisk$342
  • Phathom Pharmaceuticals, Inc.$155
  • Lilly USA, LLC$142
  • GSK$86
  • plus $532 from 18 others

What the payments were for

  • Food & beverage$2,68496%
  • Education$1164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,800 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$43,258
LinzessLinaclotide16$20,493
JardianceEmpagliflozin20$20,033
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$15,555
JanuviaSitagliptin Phosphate13$12,125
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$2,877
Levothyroxine Sodium169$1,781
Montelukast Sodium154$1,649
Atorvastatin Calcium132$1,278
Gabapentin44$1,115
Albuterol Sulfate HfaAlbuterol Sulfate54$1,071
Fenofibrate27$935
Duloxetine Hcl24$873
Omeprazole62$854
Metoprolol Succinate60$852

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$342$43,25834 claims
AbbVieLinzess$1,107$20,49316 claims
Boehringer IngelheimJardiance$48$20,03320 claims
AstraZenecaBreztri Aerosphere$437$15,55518 claims
MerckJanuvia$14$12,12513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.

Other family in Peoria

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →